Jazz Pharmaceuticals Plc (JAZZ)
214.00
-0.65
(-0.30%)
USD |
NASDAQ |
Oct 23, 16:00
213.02
-0.98
(-0.46%)
After-Hours: 20:00
Jazz Pharmaceuticals Price to Book Value : 2.888 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.888 |
| October 22, 2026 | 2.897 |
| October 21, 2026 | 2.861 |
| October 20, 2026 | 2.885 |
| October 19, 2026 | 2.813 |
| October 16, 2026 | 2.837 |
| October 15, 2026 | 2.894 |
| October 14, 2026 | 2.829 |
| October 13, 2026 | 2.839 |
| October 12, 2026 | 2.925 |
| October 09, 2026 | 2.948 |
| October 08, 2026 | 3.002 |
| October 07, 2026 | 3.12 |
| October 06, 2026 | 3.123 |
| October 05, 2026 | 3.185 |
| October 02, 2026 | 3.180 |
| October 01, 2026 | 3.144 |
| September 30, 2026 | 3.124 |
| September 29, 2026 | 3.136 |
| September 28, 2026 | 3.216 |
| September 25, 2026 | 3.211 |
| September 24, 2026 | 3.189 |
| September 23, 2026 | 3.170 |
| September 22, 2026 | 3.246 |
| September 21, 2026 | 3.259 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.249 |
| September 17, 2026 | 3.291 |
| September 16, 2026 | 3.287 |
| September 15, 2026 | 3.250 |
| September 14, 2026 | 3.318 |
| September 11, 2026 | 3.317 |
| September 10, 2026 | 3.245 |
| September 09, 2026 | 3.256 |
| September 08, 2026 | 3.240 |
| September 04, 2026 | 3.331 |
| September 03, 2026 | 3.341 |
| September 02, 2026 | 3.314 |
| September 01, 2026 | 3.289 |
| August 31, 2026 | 3.383 |
| August 28, 2026 | 3.300 |
| August 27, 2026 | 3.389 |
| August 26, 2026 | 3.364 |
| August 25, 2026 | 3.512 |
| August 24, 2026 | 3.434 |
| August 21, 2026 | 3.432 |
| August 20, 2026 | 3.356 |
| August 19, 2026 | 3.403 |
| August 18, 2026 | 3.415 |
| August 17, 2026 | 3.352 |
| August 14, 2026 | 3.306 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| GH Research Plc | 3.450 |
| Cosmo NV | -- |
| Corcept Therapeutics, Inc. | 13.13 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| PE Ratio | 14.76 |
| PS Ratio | 3.029 |
| Price to Free Cash Flow | 9.244 |
| Price | 214.00 |
| Earnings Yield | 6.78% |
| Market Cap | 13.87B |
| Operating PE Ratio | 14.60 |
| Normalized PE Ratio | 12.84 |